200 related articles for article (PubMed ID: 19477404)
1. Polymorphisms of adrenoceptors are not associated with an increased risk of adverse event in heart failure: a MERIT-HF substudy.
Savva J; Maqbool A; White HL; Galloway SL; Yuldasheva NY; Ball SG; West RM; De Boer RA; Van Veldhuisen DJ; Balmforth AJ;
J Card Fail; 2009 Jun; 15(5):435-41. PubMed ID: 19477404
[TBL] [Abstract][Full Text] [Related]
2. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
Lobmeyer MT; Gong Y; Terra SG; Beitelshees AL; Langaee TY; Pauly DF; Schofield RS; Hamilton KK; Herbert Patterson J; Adams KF; Hill JA; Aranda JM; Johnson JA
Pharmacogenet Genomics; 2007 Apr; 17(4):277-82. PubMed ID: 17496726
[TBL] [Abstract][Full Text] [Related]
3. Role of beta1- and beta2-adrenoceptor polymorphisms in heart failure: a case-control study.
Covolo L; Gelatti U; Metra M; Nodari S; Piccichè A; Pezzali N; Zani C; Alberti A; Donato F; Nardi G; Dei Cas L
Eur Heart J; 2004 Sep; 25(17):1534-41. PubMed ID: 15342173
[TBL] [Abstract][Full Text] [Related]
4. The α(2C)-Del322-325 adrenoceptor polymorphism and the occurrence of left ventricular hypertrophy in hypertensives.
Savva J; Alfakih K; Galloway SL; Hall AS; West RM; Ball SG; Balmforth AJ; Maqbool A
Blood Press; 2012 Apr; 21(2):116-21. PubMed ID: 22040172
[TBL] [Abstract][Full Text] [Related]
5. Absence of the α(2c)-adrenoceptor Del322-325 allele is associated with increased mortality in patients with chronic systolic heart failure.
Amir O; Smith Y; Zafrir B; Azzam N; Lewis BS; Fares F
J Card Fail; 2012 Dec; 18(12):925-9. PubMed ID: 23207081
[TBL] [Abstract][Full Text] [Related]
6. Adrenergic receptor polymorphisms and prevention of ventricular arrhythmias with bucindolol in patients with chronic heart failure.
Aleong RG; Sauer WH; Robertson AD; Liggett SB; Bristow MR
Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):137-43. PubMed ID: 23275278
[TBL] [Abstract][Full Text] [Related]
7. Alpha2C-adrenoceptor polymorphism is associated with improved event-free survival in patients with dilated cardiomyopathy.
Regitz-Zagrosek V; Hocher B; Bettmann M; Brede M; Hadamek K; Gerstner C; Lehmkuhl HB; Hetzer R; Hein L
Eur Heart J; 2006 Feb; 27(4):454-9. PubMed ID: 16299019
[TBL] [Abstract][Full Text] [Related]
8. Interaction between cardiac sympathetic drive and heart rate in heart failure: modulation by adrenergic receptor genotype.
Kaye DM; Smirk B; Finch S; Williams C; Esler MD
J Am Coll Cardiol; 2004 Nov; 44(10):2008-15. PubMed ID: 15542284
[TBL] [Abstract][Full Text] [Related]
9. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy.
Biolo A; Clausell N; Santos KG; Salvaro R; Ashton-Prolla P; Borges A; Rohde LE
Am J Cardiol; 2008 Sep; 102(6):726-32. PubMed ID: 18773997
[TBL] [Abstract][Full Text] [Related]
10. Relation of beta(2)-adrenoceptor haplotype to risk of death and heart transplantation in patients with heart failure.
Shin J; Lobmeyer MT; Gong Y; Zineh I; Langaee TY; Yarandi H; Schofield RS; Aranda JM; Hill JA; Pauly DF; Johnson JA
Am J Cardiol; 2007 Jan; 99(2):250-5. PubMed ID: 17223428
[TBL] [Abstract][Full Text] [Related]
11. Arg389Gly polymorphism of the human beta1-adrenergic receptor in patients with nonfatal acute myocardial infarction.
Iwai C; Akita H; Kanazawa K; Shiga N; Terashima M; Matsuda Y; Takai E; Miyamoto Y; Shimizu M; Kajiya T; Hayashi T; Yokoyama M
Am Heart J; 2003 Jul; 146(1):106-9. PubMed ID: 12851615
[TBL] [Abstract][Full Text] [Related]
12. beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure.
Terra SG; Pauly DF; Lee CR; Patterson JH; Adams KF; Schofield RS; Belgado BS; Hamilton KK; Aranda JM; Hill JA; Yarandi HN; Walker JR; Phillips MS; Gelfand CA; Johnson JA
Clin Pharmacol Ther; 2005 Mar; 77(3):127-37. PubMed ID: 15735607
[TBL] [Abstract][Full Text] [Related]
13. Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study.
Metra M; Zani C; Covolo L; Nodari S; Pezzali N; Gelatti U; Donato F; Nardi G; Dei Cas L
Eur J Heart Fail; 2006 Mar; 8(2):131-5. PubMed ID: 16188498
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants of beta(1)-adrenoceptor gene polymorphisms (Ser49Gly and Arg389Gly) and essential hypertension in a south Indian Tamil population.
Ramu P; Rajan S; Shewade DG; Swaminathan RP; Dutta TK; Balachander J; Adithan C
Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):576-82. PubMed ID: 19673943
[TBL] [Abstract][Full Text] [Related]
15. [Beta1-adrenergic receptor (Arg389Gly) polymorphism and response to bisoprolol in patients with chronic heart failure].
Yu WP; Lou M; Deng B; Song HM; Wang HB
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):776-80. PubMed ID: 17217681
[TBL] [Abstract][Full Text] [Related]
16. No positive association between adrenergic receptor variants of alpha2cDel322-325, beta1Ser49, beta1Arg389 and the risk for heart failure in the Japanese population.
Nonen S; Okamoto H; Akino M; Matsui Y; Fujio Y; Yoshiyama M; Takemoto Y; Yoshikawa J; Azuma J; Kitabatake A
Br J Clin Pharmacol; 2005 Oct; 60(4):414-7. PubMed ID: 16187973
[TBL] [Abstract][Full Text] [Related]
17. β-adrenergic receptor polymorphisms in susceptibility, response to treatment and prognosis in heart failure: implication of ethnicity.
Pereira SB; Velloso MW; Chermont S; Quintão MM; Nunes Abdhala R; Giro C; Oliveira E Alves T; Camacho V; De Fátima Maia Contarato L; Pena FM; Balieiro HM; Garcia ML; Da Nóbrega AC; Ribeiro GS; Mesquita ET
Mol Med Rep; 2013 Jan; 7(1):259-65. PubMed ID: 23064657
[TBL] [Abstract][Full Text] [Related]
18. Combinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphisms.
O'Connor CM; Fiuzat M; Carson PE; Anand IS; Plehn JF; Gottlieb SS; Silver MA; Lindenfeld J; Miller AB; White M; Walsh R; Nelson P; Medway A; Davis G; Robertson AD; Port JD; Carr J; Murphy GA; Lazzeroni LC; Abraham WT; Liggett SB; Bristow MR
PLoS One; 2012; 7(10):e44324. PubMed ID: 23071495
[TBL] [Abstract][Full Text] [Related]
19. Heterozygous alpha 2C-adrenoceptor-deficient mice develop heart failure after transverse aortic constriction.
Gilsbach R; Brede M; Beetz N; Moura E; Muthig V; Gerstner C; Barreto F; Neubauer S; Vieira-Coelho MA; Hein L
Cardiovasc Res; 2007 Sep; 75(4):728-37. PubMed ID: 17597596
[TBL] [Abstract][Full Text] [Related]
20. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
Molenaar P; Chen L; Semmler AB; Parsonage WA; Kaumann AJ
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1020-8. PubMed ID: 17714089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
